AstraZeneca Results Presentation Deck slide image

AstraZeneca Results Presentation Deck

CEO Opening Remarks 31 Financial Results Mene Pangalos to retire after almost 14 years with AstraZeneca Oncology BioPharmaceuticals R&D leadership change BioPharmaceuticals Sharon Barr to assume role of EVP, BioPharmaceuticals R&D Rare Disease CEO Closing Remarks
View entire presentation